We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Travelers Companies
TRV
$77B
| $297K | 0.01% |
2,985
+9
| +0.3% | +$920 |
|
|
CB
427
DELISTED
CHUBB CORPORATION
CB
| $296K | 0.01% |
2,416
-106
| -4% | -$13K |
|
428
Southern Company
SO
$102B
| $294K | 0.01% |
6,574
-738
| -10% | -$32.4K |
|
429
Target
TGT
$75.4B
| $294K | 0.01% |
3,735
+367
| +11% | +$29.3K |
|
430
RLI Corp
RLI
$5.89B
| $293K | 0.01% |
10,948
| – | – |
|
431
Sasol
SSL
$7.44B
| $292K | 0.01% |
10,507
-1,639
| -13% | -$52.5K |
|
|
RHT
432
DELISTED
Red Hat Inc
RHT
| $292K | 0.01% |
4,060
| – | – |
|
433
Xylem
XYL
$26.3B
| $289K | 0.01% |
8,797
-400
| -4% | -$13.5K |
|
|
RAI
434
DELISTED
Reynolds American Inc
RAI
| $289K | 0.01% |
6,539
+551
| +9% | +$22.9K |
|
435
General Dynamics
GD
$103B
| $285K | 0.01% |
2,065
+622
| +43% | +$90K |
|
436
NOV
NOV
$7.4B
| $285K | 0.01% |
7,576
| – | – |
|
437
MetLife
MET
$61.2B
| $284K | 0.01% |
6,760
+27
| +0.4% | +$1.26K |
|
|
NS
438
DELISTED
NuStar Energy L.P.
NS
| $282K | 0.01% |
6,287
| – | – |
|
439
CSX Corp
CSX
$95.5B
| $277K | 0.01% |
30,936
-7,470
| -19% | -$73.3K |
|
|
RTN
440
DELISTED
Raytheon Company
RTN
| $277K | 0.01% |
2,537
-5
| -0.2% | -$522 |
|
|
ESES
441
DELISTED
Eco-Stim Energy Solutions Inc. Common Stock
ESES
| $277K | 0.01% |
80,667
+6,500
| +9% | +$25.5K |
|
442
AptarGroup
ATR
$8.45B
| $274K | 0.01% |
4,154
| – | – |
|
443
Paychex
PAYX
$45B
| $274K | 0.01% |
5,750
+148
| +3% | +$6.9K |
|
444
iShares Russell 3000 ETF
IWV
$20.4B
| $273K | 0.01% |
2,397
+1
| +0% | +$121 |
|
|
SE
445
DELISTED
Spectra Energy Corp Wi
SE
| $273K | 0.01% |
10,400
+100
| +1% | +$2.91K |
|
446
Banco Macro
BMA
$4.91B
| $270K | 0.01% |
7,033
-1,205
| -15% | -$53.9K |
|
447
Dominion Energy
D
$58.5B
| $270K | 0.01% |
3,830
-110
| -3% | -$7.73K |
|
448
Clorox
CLX
$12.5B
| $267K | 0.01% |
2,310
-27
| -1% | -$3.03K |
|
449
Annaly Capital Management
NLY
$17.4B
| $263K | 0.01% |
6,667
-1,250
| -16% | -$50K |
|
450
State Street Technology Select Sector SPDR ETF
XLK
$123B
| $263K | 0.01% |
13,328
+24
| +0.2% | +$494 |
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.